Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Technology Developments Driving Transformational Growth in Treatment Modalities for Obstructive Lung Diseases
* Required Fields
Pay by invoice
Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not capable of curing lung diseases. Inhaled corticosteroids are widely used in the treatment of COPD and asthma, but they leave long-term side effects on patients. Treatment options such as lung transplants to treat COPD and biologics, which include monoclonal antibodies developed to treat COPD and moderate to severe asthma, are expensive and inaccessible to most patients.The administration mode of respiratory drugs also has several challenges. Oral inhalation can result in drug deposition issues where molecules in the lungs are decreased due to the administration mode, reducing the drug’s efficacy and bioavailability at the site of interest. For therapies such as gene therapies, newer approaches that go beyond viral vector deliveries such as lipid-based deliveries are being tested. The cystic fibrosis transmembrane conductance regulator (CFTR) gene can be directly delivered with lipid molecule coating to overcome particle degradation and increase target specific delivery.In this report, Frost & Sullivan provides a glimpse into the near future of respiratory disease treatment by highlighting newer therapeutics and advanced technologies that can address existing challenges in obstructive lung disease management. Frost & Sullivan has identified new therapies across six areas of high interest and growth: small molecules, biologics, gene therapy, stem cell therapy, ribonucleic acid (RNA) therapy, and combination therapies. Poor patient adherence and the lack of continuous tracking systems to monitor improvements have resulted in low outcomes. Along with newer therapeutics, advanced technologies, such as smart inhalers, and the use of digital therapeutics can enhance self-management and reduce hospitalization. The study also covers opportunities led by big pharmaceutical and medical devices companies and new collaborations in developing affordable and quality-driven treatments. Cost-effective smart technologies can help in monitoring patients, taking preventive measures, and alerting patients to possible unexpected asthma or COPD attacks. Although most of these newer therapeutics are still in the pre-clinical stage, the results have been promising and show high potential to control and cure obstructive lung diseases.Key questions addressed: • What are the current methods of treatment and their challenges? • What are the new trends and their clinical status? • What is the patent filing trend? • What are the recent research and development activities and collaborations? • What are the key companies in action?• What are the growth opportunities for companies developing new therapeutics and technologies for obstructive lung disease management?
Global Tissue Diagnostics Growth Opportunities, 2021
US Chronic Disease Management Growth Opportunities
Global Structural Heart Devices Growth Opportunities
Global Healthcare Cloud Growth Opportunities
INNOVATIONS AND GROWTH OPPORTUNITIES IN ORGAN PERFUSION AND PRESERVATION, DIGITAL THERAPEUTICS, AND WOUND ANALYSIS PLATFORMS
GROWTH OPPORTUNITIES IN PLATFORM TECHNOLOGIES, DIAGNOSTICS, AND ADVANCED THERAPEUTICS
Global Renal Care Management Growth Opportunities
GROWTH OPPORTUNITIES IN VENTILATORS, BLOOD GLUCOSE TRACKING, ORTHOPEDIC IMPLANTS, AND BRAIN VISUALIZATION PLATFORMS
GROWTH OPPORTUNITIES IN THERAPEUTICS FOR NEURODEGENERATIVE DISORDERS, IMMUNOTHERAPEUTICS, AND ADVANCED BIOLOGICS
artificial lift market
heavy truck market
smart wearables market
wireless charging market
smart home market
dietary supplements market
digital signage market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.